Old Web
English
Sign In
Acemap
>
Paper
>
92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET
92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET
2019
Melody Qu
Yujie Chen
Gregory S. Zaric
Suresh Senan
Robert Olson
Stephen Harrow
Ava John-Baptiste
Stewart Gaede
Liam Mulroy
Devin Schellenberg
Sashendra Senthi
Anand Swaminath
Neil Kopek
Mitchell Liu
Andrew Warner
George Rodrigues
David Palma
Alexander V. Louie
Keywords:
economic analysis
Medical physics
Comet
Radiology
Medicine
SABR volatility model
Cancer
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]